Evidence map›Paper›PMID 29138880›Full record

ArticleEuropean radiology2018

Morphological classification of intraductal papillary neoplasm of the bile duct.

Shihong Ying, Mingliang Ying, Wenjie Liang, Zhaoming Wang, Qidong Wang, Feng Chen, Wenbo Xiao

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. [Magnetic resonance imaging features and classification of intraductal papillary neoplasm of the bile duct].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  6. Article
  7. Article
  8. Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features.Radiographics : a review publication of the Radiological Society of North America, Inc · 2021
    Article
  9. Article
  10. Article
  11. FDG PET/CT Findings in Biliary Papillomatosis.Clinical nuclear medicine · 2020
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Shihong YingDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Mingliang YingDepartment of Radiology, Jinhua Municipal Central Hospital, 365 Renmin Dong Road, Jinhua, 321000, China.
Wenjie LiangDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Zhaoming WangDepartment of Pathology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Qidong WangDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Feng ChenDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China.
Wenbo XiaoDepartment of Radiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, Hangzhou, 310003, China. xiaowenbo@zju.edu.cn.
Zhejiang University · CNJinhua Central Hospital · CN

Funding

National Natural Science Foundation of China 81171388Zhejiang Provincial Natural Science Foundation of China Z16H180003
6 · The paper itself

Abstract

objectivesTo investigate the morphological classification of intraductal papillary neoplasm of the bile duct (IPNB), as well as morphological differences between IPNB without mucin secretion (IPNB-NM) and IPNB with mucin secretion (IPMN-B).

methodsEighty-one patients with IPNB were retrospectively analysed. Imaging examinations included computed tomography (CT), magnetic resonance imaging (MRI), gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced MRI and positron emission tomography-computed tomography (PET-CT). According to the morphology of tumours and extent of bile duct dilations, IPNB was classified into seven types: I, upstream-ductectatic type; II, typical type; III, superficial-spreading type; IV, no-mass-forming type; V, intrahepatic-cystic type; VI, extrahepatic-cystic type; and VII, infiltrating type.

resultsThirteen IPNB-NM patients comprised type I (11 cases), type II (1 case) and type VII (1 case); 68 IPMN-B patients comprised type I (2 cases), type II (30 cases), type III (6 cases), type IV (11 cases), type V (13 cases), type VI (2 cases) and type VII (4 cases). Bile duct dilations were more severe in IPMN-B than in IPNB-NM. PET-CT and Gd-EOB-DTPA-enhanced MRI clearly demonstrated the extension of infiltrating IPNB.

conclusionsIPNB can be classified into seven morphological types. IPNB-NM and IPMN-B have different morphological features. KEY POINTS: • IPNB can be classified into seven morphological types. • IPNB-NM and IPMN-B have different morphological features. • Enhanced CT and MRI can display different types of IPNB. • Morphological classification of IPNB facilitates management of the disease.

Indexed as

AdultAgedAged, 80 and overBile Duct NeoplasmsBile Ducts, IntrahepaticCarcinoma, PapillaryFemaleGadolinium DTPAHumansImage EnhancementMagnetic Resonance ImagingMaleMiddle AgedPositron Emission Tomography Computed TomographyRetrospective StudiesTomography, X-Ray ComputedGadolinium DTPAgadolinium ethoxybenzyl DTPABile ductCholangiocarcinomaComputed tomographyIntraductal papillary neoplasmMagnetic resonance imaging

Identifiers

PMID29138880
OpenAlexW2769172538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.